0001013762-23-000857.txt : 20231003
0001013762-23-000857.hdr.sgml : 20231003
20231003123851
ACCESSION NUMBER: 0001013762-23-000857
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20231003
DATE AS OF CHANGE: 20231003
EFFECTIVENESS DATE: 20231003
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scinai Immunotherapeutics Ltd.
CENTRAL INDEX KEY: 0001611747
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-493666
FILM NUMBER: 231302307
BUSINESS ADDRESS:
STREET 1: JERUSALEM BIOPARK, 2ND FLOOR
STREET 2: HADASSAH EIN KEREM CAMPUS
CITY: JERUSALEM
STATE: L3
ZIP: 00000
BUSINESS PHONE: 972-8-9302529
MAIL ADDRESS:
STREET 1: JERUSALEM BIOPARK, 2ND FLOOR
STREET 2: HADASSAH EIN KEREM CAMPUS
CITY: JERUSALEM
STATE: L3
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: BiondVax Pharmaceuticals Ltd.
DATE OF NAME CHANGE: 20140624
D
1
primary_doc.xml
X0708
D
LIVE
0001611747
Scinai Immunotherapeutics Ltd.
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
972-8-9302529
ISRAEL
None
BiondVax Pharmaceuticals Ltd.
Corporation
true
Amir
Reichman
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Executive Officer
Director
Mark
Germain
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Director
Uri
Ben Or
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Executive Officer
Avner
Rotman
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Executive Officer
Director
Yael
Margolin
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Director
Morris
Laster
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Director
Adi
Raviv
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Director
Samuel
Moed
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Director
Jay
Green
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Director
Tamar
Ben-Yedidia
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Executive Officer
Elad
Mark
JERUSALEM BIOPARK, 2ND FLOOR,
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
ISRAEL
9112001
Executive Officer
Pharmaceuticals
No Revenues
- 06b
false
2023-09-19
false
true
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVENUE
NEW YORK
NY
NEW YORK
10022
NY
NEW YORK
false
1329254
1329254
0
This Form D is being filed in connection with the issuance of warrants to purchase up to 1,146,552 American Depositary Shares ("ADSs"), each representing 400 ordinary shares, no par value, of the Company at an exercise price of $1.16 per ADS.
false
1
106400
0
The Company paid a placement agent cash fee of 7% of, and a management fee of 1% of, the aggregate gross proceeds from the sale of ADSs and Pre-Funded Warrants in a concurrent registered direct offering and also issued warrants to purchase 68,798 ADSs.
0
false
Scinai Immunotherapeutics Ltd.
/s/ Amir Reichman
Amir Reichman
Chief Executive Officer
2023-10-03